Recent Updates

Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care

Obstructive sleep apnoea in Type 2 diabetes mellitus: increased risk for overweight as well as obese people included in a national primary care database analysis

Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

Scroll to Top